Lipa-KO
品系全名
C57BL/6Smoc-Lipaem1Smoc
目录号
NM-KO-201298
品系状态
活体
基因信息
基因名
Lipa
品系描述
疾病预测
Wolman Disease
验证数据
Fig.1 Body weight of Lipa-KO and WT C57BL/6 mice. (2~4 month: n=3~6; 6 month: n=1~3)
Fig.2 ALT and AST of Lipa-KO and WT C57BL/6 mice. (2~4 month: n=3~6; 6 month: n=1~3)
Fig.3 Blood lipid profile of Lipa-KO and WT C57BL/6 mice. (2~4 month: n=3~6; 6 month: n=1~3)
Fig.4 Cholesterol content of Lipa-KO and WT C57BL/6 mice in liver and spleen. (n=1~3).
Fig.5 Gross pathology and relative weight of liver of Lipa-KO and WT C57BL/6 mice. (n=1~3).
Fig. 6 Gross pathology and relative weight of spleen of Lipa-KO and WT C57BL/6 mice. (n=1~3).
Fig.7 Gross pathology and relative weight of small intestine of Lipa-KO and WT C57BL/6 mice. (n=1~3).
Fig.8 Relative weight of WAT of Lipa-KO and WT C57BL/6 mice. (n=1~3).
Fig.9 Representative oil‐red‐staining images of liver and spleen of of 3-month old mice Lipa-KO and WT C57BL/6 mice.
Fig.10 Representative pictures of liver and spleen of 3-month old mice Lipa-KO and WT C57BL/6 mice.
Macrophages (orange arrow), fibroblast proliferation (brown arrow), and granulocyte infiltration (red arrow).
你也可能感兴趣
Cre-ERT2在无Tamoxifen诱导的情况下，在细胞质内处于无活性状态；当Tamoxifen诱导后，Tamoxifen的代谢产物4-OHT（雌激素类似物）与ERT结合，可使Cre-ERT2进核发挥Cre重组酶活性。
查看
